Cargando…
Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in adults in developed countries, with a global prevalence as high as one billion. The pathogenesis of NAFLD is a multifactorial and multi-step process. Nowadays, a growing body of research suggests the considerable...
Autores principales: | Berk, Klaudia, Bzdega, Wiktor, Konstantynowicz-Nowicka, Karolina, Charytoniuk, Tomasz, Zywno, Hubert, Chabowski, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864168/ https://www.ncbi.nlm.nih.gov/pubmed/33498537 http://dx.doi.org/10.3390/jcm10030393 |
Ejemplares similares
-
Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
por: Charytoniuk, Tomasz, et al.
Publicado: (2020) -
The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
por: Charytoniuk, Tomasz, et al.
Publicado: (2022) -
Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
por: Kołakowski, Adrian, et al.
Publicado: (2022) -
Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?
por: Drygalski, Krzysztof, et al.
Publicado: (2017) -
The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
por: Zywno, Hubert, et al.
Publicado: (2021)